{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T16:21:43Z","timestamp":1648830103832},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"published-print":{"date-parts":[[2013,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Objective<\/jats:title>\n            <jats:p>Here we report a case of a splenectomized white woman with natalizumab-associated progressive multifocal leukoencephalopathy (PML), occurring as early as after 11 infusions and provide blood fluorescence-activated cell sorting (FACS) analyses before and after natalizumab treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Design<\/jats:title>\n            <jats:p>This is a report of a single case with immunological studies.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>Methods comprised neurologic examination, magnetic resonance imaging, and cerebrospinal fluid (CSF) studies as well as immune cell FACS analyses from blood.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Diagnosis of PML was established after positive John Cunningham virus (JCV) DNA was detected in the CSF. An immune reconstitution inflammatory syndrome was treated with repeated cycles of steroid pulses and intravenous immunoglobulins. Reduced numbers of memory B cells, which might play an important role in antiviral immune response, were detected in the blood. Moreover the percentage of CD19+ B cells was elevated in our post-splenectomy patient as compared to a control cohort of multiple sclerosis (MS) patients under natalizumab therapy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Splenectomy may increase the risk for the development of natalizumab-associated PML via effects on the B cell compartment. It may be regarded as a risk factor in MS patients independent from the duration of disease.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/1742-2094-10-123","type":"journal-article","created":{"date-parts":[[2013,10,11]],"date-time":"2013-10-11T03:51:06Z","timestamp":1381463466000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Immunological and clinical consequences of splenectomy in a multiple sclerosis patient treated with natalizumab"],"prefix":"10.1186","volume":"10","author":[{"given":"De-Hyung","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne","family":"Waschbisch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexandra B","family":"L\u00e4mmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnd","family":"Doerfler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Schwab","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf A","family":"Linker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,9]]},"reference":[{"key":"1131_CR1","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1159\/000026184","volume":"17","author":"RC Holman","year":"1998","unstructured":"Holman RC, Torok TJ, Belay ED, Janssen RS, Schonberger LB: Progressive multifocal leukoencephalopathy in the United States, 1979\u20131994: increased mortality associated with HIV infection. Neuroepidemiology. 1998, 17: 303-309. 10.1159\/000026184.","journal-title":"Neuroepidemiology"},{"key":"1131_CR2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0733-8619(18)31105-8","volume":"2","author":"BR Brooks","year":"1984","unstructured":"Brooks BR, Walker DL: Progressive multifocal leukoencephalopathy. Neurol Clin. 1984, 2: 299-313.","journal-title":"Neurol Clin"},{"key":"1131_CR3","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1056\/NEJMoa044397","volume":"354","author":"CH Polman","year":"2006","unstructured":"Polman CH, O\u2019Connor PW, Havrdova E, Hutchinson M, Kappos L, Miller DH, Phillips JT, Lublin FD, Giovannoni G, Wajgt A, Toal M, Lynn F, Panzara MA, Sandrock AW, AFFIRM Investigators: A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2006, 354: 899-910. 10.1056\/NEJMoa044397.","journal-title":"N Engl J Med"},{"key":"1131_CR4","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C, Subramanyam M, Goelz S, Natarajan A, Lee S, Plavina T, Scanlon JV, Sandrock A, Bozic C: Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med. 2012, 366: 1870-1880. 10.1056\/NEJMoa1107829.","journal-title":"N Engl J Med"},{"key":"1131_CR5","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/S0140-6736(10)61493-6","volume":"378","author":"A Di Sarbatino","year":"2011","unstructured":"Di Sarbatino A, Carsetti R, Corazza GR: Post-splenectomy and hyposplenic states. Lancet. 2011, 378: 86-97. 10.1016\/S0140-6736(10)61493-6.","journal-title":"Lancet"},{"key":"1131_CR6","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/j.0300-9475.2004.01379.x","volume":"59","author":"M Karakantza","year":"2004","unstructured":"Karakantza M, Theodorou GL, Mouzaki A, Theodori E, Vagianos C, Maniatis A: In vitro study of the long-term effects of post-traumatic splenectomy on cellular immunity. Scand J Immunol. 2004, 59: 209-219. 10.1111\/j.0300-9475.2004.01379.x.","journal-title":"Scand J Immunol"},{"key":"1131_CR7","doi-asserted-by":"publisher","first-page":"1275","DOI":"10.1038\/nn1005-1275","volume":"8","author":"RM Ransohoff","year":"2005","unstructured":"Ransohoff RM: Natalizumab and PML. Nat Neurosci. 2005, 8: 1275-10.1038\/nn1005-1275.","journal-title":"Nat Neurosci"},{"key":"1131_CR8","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jneuroim.2007.11.007","volume":"194","author":"RL Lindberg","year":"2008","unstructured":"Lindberg RL, Achtnichts L, Hoffmann F, Kuhle J, Kappos L: Natalizumab alters transcriptional expression profiles of blood cell subpopulations of multiple sclerosis patients. J Neuroimmunol. 2008, 194: 153-164. 10.1016\/j.jneuroim.2007.11.007.","journal-title":"J Neuroimmunol"},{"key":"1131_CR9","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1002\/eji.201142108","volume":"42","author":"R Planas","year":"2012","unstructured":"Planas R, Jelcic I, Schippling S, Martin R, Sospedra M: Natalizumab treatment perturbs memory- and marginal zone-like B-cell homing in secondary lymphoid organs in multiple sclerosis. Eur J Immunol. 2012, 42: 790-798. 10.1002\/eji.201142108.","journal-title":"Eur J Immunol"},{"key":"1131_CR10","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1212\/01.wnl.0000327671.91357.96","volume":"71","author":"M Krumbholz","year":"2008","unstructured":"Krumbholz M, Meinl I, Kumpfel T, Hohlfeld R, Meinl E: Natalizumab disproportionately increases circulating pre-B and B cells in multiple sclerosis. Neurology. 2008, 71: 1350-1354. 10.1212\/01.wnl.0000327671.91357.96.","journal-title":"Neurology"},{"key":"1131_CR11","doi-asserted-by":"publisher","first-page":"e47578","DOI":"10.1371\/journal.pone.0047578","volume":"7","author":"L Bornsen","year":"2012","unstructured":"Bornsen L, Christensen JR, Ratzer R, Oturai AB, Sorensen PS, Sondergaard HB, Sellebjerg F: Effect of natalizumab on circulating CD4+ T-cells in multiple sclerosis. PLoS One. 2012, 7: e47578-10.1371\/journal.pone.0047578.","journal-title":"PLoS One"},{"key":"1131_CR12","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1001\/archneurol.2011.238","volume":"68","author":"C Saure","year":"2011","unstructured":"Saure C, Warnke C, Zohren F, Schroeder T, Bruns I, Cadeddu RP, Weigelt C, Fischer U, Kobbe G, Hartung HP, Adams O, Kieseier BC, Haas R: Natalizumab and impedance of the homing of CD34+ hematopoietic progenitors. Arch Neurol. 2011, 68: 1428-1431. 10.1001\/archneurol.2011.238.","journal-title":"Arch Neurol"},{"key":"1131_CR13","doi-asserted-by":"publisher","first-page":"3439","DOI":"10.1182\/blood-2007-09-112052","volume":"111","author":"H Bonig","year":"2008","unstructured":"Bonig H, Wundes A, Chang KH, Lucas S, Papayannopoulou T: Increased numbers of circulating hematopoietic stem\/progenitor cells are chronically maintained in patients treated with the CD49d blocking antibody natalizumab. Blood. 2008, 111: 3439-3441. 10.1182\/blood-2007-09-112052.","journal-title":"Blood"},{"key":"1131_CR14","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1177\/1352458510385834","volume":"17","author":"C Warnke","year":"2011","unstructured":"Warnke C, Smolianov V, Dehmel T, Andr\u00e9e M, Hengel H, Zohren F, Arendt G, Wiendl H, Haas R, Hartung HP, Adams O, Kieseier BC: CD34+ progenitor cells mobilized by natalizumab are not a relevant reservoir for JC virus. Mult Scle. 2011, 17: 151-156. 10.1177\/1352458510385834.","journal-title":"Mult Scle"},{"key":"1131_CR15","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1086\/653823","volume":"202","author":"ML Chapagain","year":"2010","unstructured":"Chapagain ML, Nerurkar VR: Human polyomavirus JC (JCV) infection of human B lymphocytes: a possible mechanism for JCV transmigration across the blood\u2013brain barrier. J Infect Dis. 2010, 202: 184-191. 10.1086\/653823.","journal-title":"J Infect Dis"},{"key":"1131_CR16","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1111\/ane.12080","volume":"128","author":"S Marousi","year":"2013","unstructured":"Marousi S, Karkanis I, Kalamatas T, Travasarou M, Paterakis G, Karageorgiou CE: Immune cells after prolonged Natalizumab therapy: implications for effectiveness and safety. Acta Neurol Scand. 2013, 128: e1-e5. 10.1111\/ane.12080.","journal-title":"Acta Neurol Scand"},{"key":"1131_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.3109\/13550289909021994","volume":"5","author":"R Caldarelli-Stefano","year":"1999","unstructured":"Caldarelli-Stefano R, Vago L, Omodeo-Zorini E, Mediati M, Losciale L, Nebuloni M, Costanzi G, Ferrante P: Detection and typing of JC virus in autopsy brains and extraneural organs of AIDS patients and non-immunocompromised individuals. J Neurovirol. 1999, 5: 125-133. 10.3109\/13550289909021994.","journal-title":"J Neurovirol"},{"key":"1131_CR18","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1056\/NEJM198802043180507","volume":"318","author":"SA Houff","year":"1988","unstructured":"Houff SA, Major EO, Katz DA, Kufta CV, Sever JL, Pittaluga S, Roberts JR, Gitt J, Saini N, Lux W: Involvement of JC virus-infected mononuclear cells from the bone marrow and spleen in the pathogenesis of progressive multifocal leukoencephalopathy. N Engl J Med. 1988, 318: 301-305. 10.1056\/NEJM198802043180507.","journal-title":"N Engl J Med"},{"key":"1131_CR19","doi-asserted-by":"publisher","first-page":"e23164","DOI":"10.1371\/journal.pone.0023164","volume":"6","author":"PU Cameron","year":"2011","unstructured":"Cameron PU, Jones P, Gorniak M, Dunster K, Paul E, Lewin S, Woolley I, Spelman D: Splenectomy associated changes in IgM memory B cells in an adult spleen registry cohort. PLoS One. 2011, 6: e23164-10.1371\/journal.pone.0023164.","journal-title":"PLoS One"},{"key":"1131_CR20","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1136\/jcp.32.10.1045","volume":"32","author":"RE Millard","year":"1979","unstructured":"Millard RE, Banerjee DK: Changes in T and B blood lymphocytes after splenectomy. J Clin Pathol. 1979, 32: 1045-1049. 10.1136\/jcp.32.10.1045.","journal-title":"J Clin Pathol"},{"key":"1131_CR21","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s10096-010-1049-1","volume":"29","author":"AP De Porto","year":"2010","unstructured":"De Porto AP, Lammers AJ, Bennink RJ, ten Berge IJ, Speelman P, Hoekstra JB: Assessment of splenic function. Eur J Clin Microbiol Infect Dis. 2010, 29: 1465-1473. 10.1007\/s10096-010-1049-1.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"1131_CR22","doi-asserted-by":"publisher","first-page":"3647","DOI":"10.1182\/blood-2004-01-0346","volume":"104","author":"S Weller","year":"2004","unstructured":"Weller S, Braun MC, Tan BK, Rosenwald A, Cordier C, Conley ME, Plebani A, Kumararatne DS, Bonnet D, Tournilhac O, Tchernia G, Steiniger B, Staudt LM, Casanova JL, Reynaud CA, Weill JC: Human blood IgM \u201cmemory\u201d B cells are circulating splenic marginal zone B cells harboring a prediversified immunoglobulin repertoire. Blood. 2004, 104: 3647-3654. 10.1182\/blood-2004-01-0346.","journal-title":"Blood"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/1742-2094-10-123.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T19:38:36Z","timestamp":1630611516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jneuroinflammation.biomedcentral.com\/articles\/10.1186\/1742-2094-10-123"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,9]]},"references-count":22,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["1131"],"URL":"https:\/\/doi.org\/10.1186\/1742-2094-10-123","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,9]]},"assertion":[{"value":"2 June 2013","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2013","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2013","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"123"}}